Literature DB >> 2600138

Selective secretion of alternatively spliced fibronectin variants.

J E Schwarzbauer1, C S Spencer, C L Wilson.   

Abstract

We demonstrate that the alternatively spliced variable (V) region of fibronectin (FN) is required for secretion of FN dimers during biosynthesis. Alternative splicing of the V segment of the rat FN transcript generates three subunit variants (V120, V95, V0) that differ by the inclusion or omission of an additional 120 or 95 amino acids. We are exploring the functions of this segment by expressing variant cDNAs in normal and transformed fibroblasts. Like FN itself, the cDNA-encoded polypeptides (deminectins [DNs]) containing the V120 or V95 segment are efficiently secreted as disulfide-bonded homodimers. However, few homodimers of DNs lacking this region, V0 DNs, are secreted. V0 homodimers do form inside the cell, as demonstrated by biosynthetic analyses of dimer formation and secretion using pulse-chase and time course experiments, but these dimers seldom reach the cell surface and are probably degraded intracellularly. Coexpression of V0 and V120 subunits results in intracellular formation of three types of dimers, V0-V0, V0-V120, and V120-V120, but only the V120-containing dimers are secreted. This selective retention of V0 homodimers indicates that the V region is required for formation and secretion of native FN dimers. In an analogous in vivo situation, we show that plasma FN also lacks V0-V0 dimers and consists of V0-V+ and V+-V+ combinations. Dissection of V region sequences by deletion mapping localizes the major site involved in DN dimer secretion to an 18-amino acid segment within V95. In addition, high levels of dimer secretion can be restored by insertion of V into a heterologous site 10 kD COOH terminal to its normal location. We discuss the potential role of intracellular protein-protein interactions in FN dimer formation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600138      PMCID: PMC2115891          DOI: 10.1083/jcb.109.6.3445

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  45 in total

1.  Probing molecular polymorphism of fibronectins with antibodies directed to the alternatively spliced peptide segments.

Authors:  K Sekiguchi; K Titani
Journal:  Biochemistry       Date:  1989-04-18       Impact factor: 3.162

2.  On the origin of species of fibronectin.

Authors:  J E Schwarzbauer; J I Paul; R O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

3.  Gel protein stains: silver stain.

Authors:  C R Merril; D Goldman; M L Van Keuren
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

4.  Subunit interactions in human plasma fibronectin.

Authors:  R M Robinson; J Hermans
Journal:  Biochem Biophys Res Commun       Date:  1984-11-14       Impact factor: 3.575

5.  Preparation of functionally intact monomers by limited disulfide reduction of human plasma fibronectin dimers.

Authors:  G A Homandberg; D L Amrani; D B Evans; C M Kane; E Ankel; M W Mosesson
Journal:  Arch Biochem Biophys       Date:  1985-05-01       Impact factor: 4.013

6.  Human cellular fibronectin: comparison of the carboxyl-terminal portion with rat identifies primary structural domains separated by hypervariable regions.

Authors:  M P Bernard; M Kolbe; D Weil; M L Chu
Journal:  Biochemistry       Date:  1985-05-21       Impact factor: 3.162

7.  Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene.

Authors:  A R Kornblihtt; K Umezawa; K Vibe-Pedersen; F E Baralle
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

8.  Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas.

Authors:  D G Bole; L M Hendershot; J F Kearney
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

9.  Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells.

Authors:  J B McCarthy; S T Hagen; L T Furcht
Journal:  J Cell Biol       Date:  1986-01       Impact factor: 10.539

10.  Reduced level of secretion and absence of subunit combination for the fibroin synthesized by a mutant silkworm, Nd(2).

Authors:  F Takei; F Oyama; K Kimura; A Hyodo; S Mizuno; K Shimura
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

View more
  27 in total

1.  Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin.

Authors:  A A Rostagno; J E Schwarzbauer; L I Gold
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

Review 2.  Fibronectin: functional character and role in alcoholic liver disease.

Authors:  Razia S Aziz-Seible; Carol A Casey
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

3.  Characterization of mouse fibronectin alternative mRNAs reveals an unusual isoform present transiently during liver development.

Authors:  G K Górski; M C Aros; P A Norton
Journal:  Gene Expr       Date:  1996

4.  A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices.

Authors:  P Sriramarao; M A Bourdon
Journal:  Nucleic Acids Res       Date:  1993-01-11       Impact factor: 16.971

Review 5.  Fibronectins, their fibrillogenesis, and in vivo functions.

Authors:  Jean E Schwarzbauer; Douglas W DeSimone
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

6.  Fibronectin matrix assembly requires distinct contributions from Rho kinases I and -II.

Authors:  Atsuko Yoneda; Dmitriy Ushakov; Hinke A B Multhaupt; John R Couchman
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

Review 7.  Pathophysiological aspects of VLA-4 interactions and possibilities for therapeutical interventions.

Authors:  T W Kuijpers
Journal:  Springer Semin Immunopathol       Date:  1995

Review 8.  Emerging roles of fibronectin in thrombosis.

Authors:  Lisa M Maurer; Bianca R Tomasini-Johansson; Deane F Mosher
Journal:  Thromb Res       Date:  2010-02-08       Impact factor: 3.944

Review 9.  Fibronectin maintains the balance between hemostasis and thrombosis.

Authors:  Yiming Wang; Heyu Ni
Journal:  Cell Mol Life Sci       Date:  2016-04-21       Impact factor: 9.261

Review 10.  New insights into form and function of fibronectin splice variants.

Authors:  E S White; F E Baralle; A F Muro
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.